Related Experiment Video

Updated: May 23, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Dendritic cell therapy in advanced gastric cancer: a promising new hope?

Mallika Tewari1, Shipra Sahai, Raghvendra R Mishra

  • 1Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, 7 SKG Colony, Lanka, Varanasi 221005, U.P., India.

Surgical Oncology
|April 24, 2012
PubMed

Insights

Advanced gastric cancer has a poor prognosis, but new treatments offer hope. This review explores dendritic cell (DC) therapy for gastric cancer, summarizing tumor immunology and current research.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapy

Background:

  • Advanced gastric cancer, especially unresectable tumors, has a dismal prognosis despite current chemotherapy.
  • Trastuzumab, a monoclonal antibody, represents a breakthrough for HER2-positive metastatic gastric cancer.
  • Dendritic cells (DCs) are being investigated in various cancers, showing promise for patient management.

Purpose of the Study:

  • To review tumor immunology relevant to gastric cancer.
  • To summarize current data on the use of dendritic cells (DCs) in gastric cancer therapy.
  • To provide an overview of novel therapeutic strategies for advanced gastric cancer.

Main Methods:

  • Literature review of tumor immunology.
  • Analysis of clinical trial data on dendritic cell therapy in malignancies.
  • Synthesis of existing research on DCs for gastric cancer treatment.

Main Results:

  • Dendritic cell therapy is an emerging approach in cancer immunotherapy.
  • Current data suggests potential efficacy of DCs in managing certain human malignancies.
  • Understanding tumor immunology is crucial for developing effective DC-based therapies.

Conclusions:

  • Dendritic cell therapy holds promise as a future treatment for gastric cancer.
  • Further research is needed to optimize DC-based strategies for gastric cancer patients.
  • Combining DC therapy with other modalities may improve outcomes in advanced gastric cancer.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...